METASTATIC PAPILLARY RENAL CELL CARCINOMA
Clinical trials for METASTATIC PAPILLARY RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PAPILLARY RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PAPILLARY RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria boost may help kidney cancer drugs work better
Disease control OngoingThis early-phase study looks at whether adding a probiotic called CBM588 to the usual two-drug treatment (cabozantinib and nivolumab) can improve outcomes for people with advanced kidney cancer that has spread. The probiotic is meant to increase helpful gut bacteria, which may he…
Matched conditions: METASTATIC PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New combo therapy shows promise for rare kidney cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to the standard drug cabozantinib works better than cabozantinib alone for people with advanced papillary kidney cancer that has spread. About 200 participants will receive either the combination or cabozantinib …
Matched conditions: METASTATIC PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC